Immunohistochemical analysis of COOH-termini of amyloid beta protein (aβ using end-specific antisera for aβ40 and aβ42 in Alzheimer's disease and normal aging

Amyloid

Volumn 2, Issue 1, 1995, Pages 7-16

  Yamaguchi, Haruyasu ^a   Sugihara, Shiro ^b   Ishiguro, Koji ^c   Takashima, Akihiko ^d   Hirai, Shunsaku ^c  

^a GUNMA UNIVERSITY   (Japan)

^b Gunma Cancer Center   (Japan)

^c GUNMA UNIVERSITY   (Japan)

^d MITSUBISHI KASEI INST OF LIFE SCI   (Japan)

Author keywords

Alzheimer's diseae (AD); Amyloid angiopathy; Amyloid beta protein(a ); End specific antiserumaging; Neurofibrillary tangles; Senile plaques

Indexed keywords

EID: 0029167555     PISSN: 13506129     EISSN: None     Source Type: Journal    
DOI: 10.3109/13506129509031882     Document Type: Article

References (46)

1. Alzhemer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein
2. Amyloid plaque core protein in Alzheimer disease and Down syndrome
3. The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome
4. The occult aftermath of boxing
5. Hereditary cerebral hemorrhage with amyloidosis in patients of Dutch origin is related to Alzheimer disease
6. Beta-amyloid protein of Alzheimer's disease is found in cerebral and spinal cord vascular malformations
7. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
8. Protein chemical and immunohistochemical studies of meningovascular β-amyloid protein in Alzheimer's disease and normal aging
9. Differences between vascular and plaque core amyloid in Alzheimer's disease
10. Mass spectrometry of purified amyloid protein in Alzheimer's disease
11. Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease
12. Structural alterations in the peptide backbone of β-amyloid core protein may account for its deposition and stability in Alzheimer's disease
13. β-amyloid-(1–42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer's disease
14. Solution conformation and aggregational properties of synthetic amyloid β-peptides of Alzheimer's disease: analysis of circular dichroism spectra
15. Seeding “one-dimensional crystallization” of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?
16. The carboxyl terminus of the β amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimers disease
17. A pathogenetic mutation for probable Alzheimer's disease in the APP gene at the N-ter-minus of β-amyloid
18. Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production
19. Release of excess amyloid beta protein from a mutant amyloid β protein precursor
20. Segregation of missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
21. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease
22. An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (βAPP717) mutants
23. Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is AB42(43)
24. Development of monoclonal antibody specific for the COOH-terminus of β-amyloid 1–42 and its immunohistochemical reactivity in Alzheimer's disease and related disorders
25. A variety of cerebral amyloid deposits in the brains of the Alzheimer-type dementia demonstrated by β protein immunostaining
26. Presence of apolipoprotein E on extracellular neurofibrillary tangles and on meningeal blood vessels precedes the Alzheimer β-amyloid deposition
27. Tau protein kinase I is essential for amyloid β-protein-induced neurotoxicity
28. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range of 1 to 100kDa
29. Diagnosis of Alzheimer's disease
30. Cerebral β amyloid deposition in the patients with malignant neoplasms: its incidence with aging and effect of radiation therapy on vascular amyloid
31. Diffuse type of senile plaques in the cerebellum of Alzheimer-type dementia demonstrated by β proteir immunostain
32. Beta amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer's disease: an immunoelectron microscopic study
33. Relative abundance of Alzheimer Aβ amyloid peptide variants in Alzheimer disease and normal aging
34. High tissue content of soluble βl-40 is linked to cerebral amyloid angiopathy
35. Amyloid protein and neurofibrillary tangles coexist in the same neuron in Alzheimer disease
36. Monoclonal antibodies to a synthetic peptide homologous with the first 28 amino acids of Alzheimer's disease b-protein recognize amyloid and diverse glial and neuronal cell types in the central nervous system
37. Amyloid beta-peptide is produced by cultured cells during normal metabolism
38. Production of the Alzheimer amyloid β protein by normal proteolytic processing
39. Generation of β-amyloid in neuronal and nonneuronal cells
40. Neurofibrillary tangles in some cases of dementia pugilistica share antigens with amyloid β-protein of Alzheimer's disease
41. Secondary deposition of β amyloid within extracellular neurofibrillary tangles in Alzheimer-type dementia
42. Ultrastructural localization of β-amyloid, T, and ubiquitin epitopes in extracellular neurofibrillary tangles
43. Topographical relationship between β amyloid and tau protein epitopes in tangle-bearing cells in Alzheimer disease
44. P Protein immunoreactivity is found in the majority of neurofibrillary tangles of Alzheimer's disease
45. Amyloid β protein precursor is bound to neurofibrillary tangles in Alzheimer-type dementia
46. Immunocytochemical evidence that the beta-protein precursor is an integral component of neurofibrillary tangles of Alzheimer's disease